11-66713635-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_Very_StrongBP7BS2_Supporting

The NM_006946.4(SPTBN2):​c.768C>T​(p.Pro256Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000165 in 1,613,228 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00016 ( 2 hom. )

Consequence

SPTBN2
NM_006946.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.45

Publications

0 publications found
Variant links:
Genes affected
SPTBN2 (HGNC:11276): (spectrin beta, non-erythrocytic 2) Spectrins are principle components of a cell's membrane-cytoskeleton and are composed of two alpha and two beta spectrin subunits. The protein encoded by this gene (SPTBN2), is called spectrin beta non-erythrocytic 2 or beta-III spectrin. It is related to, but distinct from, the beta-II spectrin gene which is also known as spectrin beta non-erythrocytic 1 (SPTBN1). SPTBN2 regulates the glutamate signaling pathway by stabilizing the glutamate transporter EAAT4 at the surface of the plasma membrane. Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. [provided by RefSeq, Dec 2009]
SPTBN2 Gene-Disease associations (from GenCC):
  • autosomal recessive spinocerebellar ataxia 14
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • spinocerebellar ataxia type 5
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 11-66713635-G-A is Benign according to our data. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-66713635-G-A is described in CliVar as Benign/Likely_benign. Clinvar id is 586492.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.45 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBN2NM_006946.4 linkc.768C>T p.Pro256Pro synonymous_variant Exon 8 of 38 ENST00000533211.6 NP_008877.2 O15020-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBN2ENST00000533211.6 linkc.768C>T p.Pro256Pro synonymous_variant Exon 8 of 38 5 NM_006946.4 ENSP00000432568.1 O15020-1

Frequencies

GnomAD3 genomes
AF:
0.000178
AC:
27
AN:
152050
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000255
AC:
64
AN:
251316
AF XY:
0.000258
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000867
Gnomad ASJ exome
AF:
0.00427
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000105
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000164
AC:
239
AN:
1461060
Hom.:
2
Cov.:
31
AF XY:
0.000166
AC XY:
121
AN XY:
726916
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33464
American (AMR)
AF:
0.000134
AC:
6
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00386
AC:
101
AN:
26134
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86238
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53162
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5734
European-Non Finnish (NFE)
AF:
0.0000990
AC:
110
AN:
1111526
Other (OTH)
AF:
0.000265
AC:
16
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152168
Hom.:
0
Cov.:
31
AF XY:
0.000148
AC XY:
11
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.000169
AC:
7
AN:
41482
American (AMR)
AF:
0.00
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68022
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000394
Hom.:
1
Bravo
AF:
0.000196
EpiCase
AF:
0.000218
EpiControl
AF:
0.000178

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Dec 11, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 05, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SPTBN2: BP4, BP7 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.43
DANN
Benign
0.64
PhyloP100
-3.4
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201821131; hg19: chr11-66481106; COSMIC: COSV100018520; COSMIC: COSV100018520; API